Int. Journal of Clinical Pharmacology and Therapeutics, Volume 57 (2019) - November (561 - 566)

Relationship between the blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplant recipients

Ryosuke Ota1, Atsushi Hirata1, Keisuke Noto1, Satoshi Yokoyama2, Kouichi Hosomi2, Mitsutaka Takada2, Hiroshi Matsuoka1
1 Department of Pharmacy, Kindai University Nara Hospital, Ikoma, Nara, and 
 2 Division of Clinical Drug Informatics, School of Pharmacy, Kindai University, Higashi-osaka, Osaka, Japan

Add to Cart  

 

DOI 10.5414/CP203539

Abstract

Objective: We aimed to clarify the drug interaction between tacrolimus and voriconazole and investigate the relationship between blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplantation (HSCT) patients.

Materials and methods: A retrospective study was conducted to investigate the relationship between blood concentration of tacrolimus and that of voriconazole at the Kindai University Nara Hospital. Patients who received HSCT and tacrolimus and were prescribed voriconazole for the prevention or treatment of aspergillosis from April 2010 to July 2018 were identified from the medical records. A total of 13 patients (administration route of tacrolimus: intravenously in 6 patients, orally in 7 patients) were enrolled in the present study.

Results: No significant correlation was observed between the blood concentration/dose (C/D) ratio of tacrolimus and the blood concentration of voriconazole (r = 0.38; p = 0.402; y = 102.8x + 928.1). However, a significant correlation was observed between the C/D ratio of tacrolimus and the blood concentration of voriconazole in the intravenous-administration group (r = 0.94; p = 0.0048; y = 421.9x + 810.5). Meanwhile, no significant correlation was observed in the oral-administration group (r = 0.43; p = 0.34; y = 7.9x + 719).

Conclusion: The C/D ratio of tacrolimus was significantly correlated with the blood concentration of voriconazole when tacrolimus was intravenously administered. There was a difference in the mechanism of drug interaction between tacrolimus and voriconazole depending on the administration routes.

Author Details

Authors

Departments

  • 1 Department of Pharmacy, Kindai University Nara Hospital, Ikoma, Nara, and 

  • 2 Division of Clinical Drug Informatics, School of Pharmacy, Kindai University, Higashi-osaka, Osaka, Japan

Address


Mitsutaka Takada, PhD
Division of Clinical Drug Informatics
School of Pharmacy, Kindai University
3-4-1, Kowakae, Higashi-osaka, Osaka, 577-8502, Japan
Email: [email protected]

Log in for Subscribers

Citation

Ota R, Hirata A, Noto K, Yokoyama S, Hosomi K, Takada M, Matsuoka H.Relationship between the blood concentrations of tacrolimus and voriconazole in hematopoietic stem cell transplant recipients
. Int J Clin Pharmacol Ther. 2019; 57: 561-566. doi: 10.5414/CP203539. Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/31426903; PMID: 31426903.

###article_not_exists_msg###

Shopping Overview

Shopping Overview
Type Qtty Discount VAT Price
Your basket is empty
View Cart